医学
内科学
心脏病学
冠状动脉痉挛
冠状动脉疾病
冠状动脉粥样硬化
血管痉挛
心绞痛
内皮功能障碍
心肌梗塞
蛛网膜下腔出血
作者
Dario Pellegrini,Regina E. Konst,Stijn C.H. van den Oord,Aukelien C. Dimitriu‐Leen,Jan‐Quinten Mol,Tijn P.J. Jansen,Angela H.E.M. Maas,Helmut Gehlmann,Robert‐Jan van Geuns,Suzette E. Elias‐Smale,Niels van Royen,Peter Damman
出处
期刊:Eurointervention
[European Association of Percutaneous Cardiovascular Interventions]
日期:2022-08-01
卷期号:18 (5): e397-e404
被引量:10
标识
DOI:10.4244/eij-d-21-00875
摘要
An association between atherosclerosis and coronary vasospasm has previously been suggested. However, to date, no conclusive data on the whole spectrum of these disorders have been published.This study aimed to define specific morphological features of atherosclerosis in patients with angina and no obstructive coronary artery disease (ANOCA) due to coronary vasospasm.From February 2019 to January 2020, we enrolled 75 patients referred to our laboratory for a coronary function test (CFT) due to ANOCA and suspected coronary vasomotor dysfunction. The CFT consisted of an acetylcholine test and a physiology assessment with hyperaemic indexes using adenosine. Patients were divided into two groups according to the presence or absence of coronary vasospasm triggered by acetylcholine (ACH+ and ACH-, respectively). In addition, optical coherence tomography (OCT) was performed to assess the lipid index (LI), a surrogate for lipid area, and the prevalence of markers of plaque vulnerability.ACH+ patients had a higher LI than ACH- patients (LI: 819.85 [460.95-2489.03] vs 269.95 [243.50-878.05], respectively, p=0.03), and a higher prevalence of vulnerable plaques (66% vs 38%, p=0.04). Moreover, ACH+ patients showed a higher prevalence of neovascularisation compared to ACH- subjects (37% vs 6%, p=0.02) and a trend towards a higher prevalence of all individual markers, in particular thin-cap fibroatheroma (20% vs 0%, p=0.06). No differences were detected between patterns of coronary vasospasm.The presence of coronary vasospasm, regardless of its phenotype, is associated with higher lipid burden, plaque vulnerability and neovascularisation.
科研通智能强力驱动
Strongly Powered by AbleSci AI